Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
There is no monthly membership or platform fee
Despite Wegovy and Zepbound being approved for patients with a body mass index of 30 or greater, and 27 or greater for those with at least one weight-related ailment, some insurance plans require a higher BMI or additional criteria for coverageif they cover medications for obesity at all
10.1002/trc2.12268 64 OhG
The presence of GLP-1 receptors in brain regions central to reward processing (Lpez-Ojeda & Hurley, 2024), together with evidence that GLP-1 RAs can modulate activity within these circuits (Gabery et al., 2020), has led to the hypothesis that GLP-1 RAs may reduce vulnerability to multiple maladaptive reward-seeking behaviors by blunting neuroaffective responses to reward-related cues (Eren-Yazicioglu et al., 2021
It is designed to be as intuitive as a social feed, but built with the rigor of a clinic
Obesity and insulin resistance sustain elevated circulating concentrations of pro-inflammatory cytokines including Tumour Necrosis Factor-alpha (TNF-), Interleukin-1 (IL-1), and Interleukin-6 (IL-6) molecules that promote DNA damage, tumour angiogenesis, and immune evasion
US$ 26.71
US$ 29.28
US$ 27.74
